FDA panel rejects Pfizer’s arthritis drug as too risky
March 26 2021, 08:00
U.S. health advisers sharply criticized an experimental arthritis drug Thursday, saying that it was too risky, even with limits on its use.
U.S. health advisers sharply criticized an experimental arthritis drug Thursday, saying that it was too risky, even with limits on its use.
Source:
FOX News